The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma according to prior lines of treatment and refractory status: IKEMA subgroup analysis.
 
Roman Hajek
Consulting or Advisory Role - Abbvie; Amgen; BMS; Celgene; Janssen-Cilag; Novartis; PharmaMar; Takeda
Speakers' Bureau - Amgen; Takeda
Research Funding - Amgen (Inst); BMS (Inst); Celgene (Inst); Novartis (Inst); Takeda (Inst)
 
Philippe Moreau
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi
 
Bradley Augustson
No Relationships to Disclose
 
Nelson Castro
No Relationships to Disclose
 
Tomas Pika
No Relationships to Disclose
 
Sosana Delimpasi
Consulting or Advisory Role - Amgen; Amgen; Janssen; Takeda
Speakers' Bureau - Amgen; Janssen; Takeda
 
Javier de La Rubia
Speakers' Bureau - Amgen; Bristol-Myers Squibb
Expert Testimony - Amgen; Celgene; Janssen
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Janssen; Sanofi
 
Angelo Maiolino
No Relationships to Disclose
 
Tony J. Reiman
Research Funding - Canadian Cancer Society; Canadian Institutes of Health Research (CIHR); New Brunswick Health Research Foundation; New Brunswick Innovation Foundation; Sanofi; TERRY FOX RESEARCH INSTITUTE
Other Relationship - Canadian Cancer Trials Group
 
Irina Kryuchkova
No Relationships to Disclose
 
Joaquin Martinez-Lopez
Honoraria - BMS Brazil; Incyte; Janssen; Novartis; Roche; Sanofi
Research Funding - BMS Brazil; Incyte; Janssen; Novartis; Roche
(OPTIONAL) Uncompensated Relationships - BMS Brazil; Janssen; Novartis
 
Thomas G. Martin
Consulting or Advisory Role - GlaxoSmithKline; Juno Therapeutics
Research Funding - AMGEN (Inst); Janssen Oncology; Janssen Oncology; Sanofi (Inst)
 
Joseph Mikhael
Honoraria - Amgen; Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
 
Kwee Yong
Honoraria - Amgen; Janssen-Cilag; Roche/Genentech; Sanofi; Takeda
Consulting or Advisory Role - Janssen-Cilag
Speakers' Bureau - Sanofi; Takeda; Takeda
Research Funding - Amgen; Autolus; Janssen-Cilag; Sanofi; Takeda (Inst)
Travel, Accommodations, Expenses - Takeda
 
Marie-Laure Risse
Employment - sanofi
 
Gaëlle Asset
Employment - Sanofi
 
Sylvia Marion
Employment - Sanofi
 
Meletios A. Dimopoulos
Honoraria - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Takeda